Insmed Inc. Files 8-K/A Amendment

TL;DR

Insmed filed an 8-K/A amendment on 4/24/25 for 'Other Events' - no new info provided.

AI Summary

Insmed Incorporated filed an 8-K/A on April 24, 2025, to amend a previous filing. The amendment pertains to 'Other Events' and does not specify any new material information beyond the initial report's scope. The company, incorporated in Virginia with its principal executive offices in Bridgewater, New Jersey, is in the Pharmaceutical Preparations industry.

Why It Matters

This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, though the specific nature of the amendment is not detailed in the provided text.

Risk Assessment

Risk Level: low — The filing is an amendment to a previous report and does not introduce new material events or financial information.

Key Numbers

• 000-30739 — SEC File Number (Identifies the company's filings with the SEC.)
• 54-1972729 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Insmed Incorporated (company) — Registrant
• Virginia (jurisdiction) — State of incorporation
• Bridgewater, New Jersey (location) — Principal executive offices
• April 24, 2025 (date) — Date of report

FAQ

From the Filing

0001140361-25-015487.txt : 20250424 0001140361-25-015487.hdr.sgml : 20250424 20250424170917 ACCESSION NUMBER: 0001140361-25-015487 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250424 ITEM INFORMATION: Other Events FILED AS OF DATE: 20250424 DATE AS OF CHANGE: 20250424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSMED Inc CENTRAL INDEX KEY: 0001104506 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 541972729 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30739 FILM NUMBER: 25868844 BUSINESS ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-977-9900 MAIL ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: INSMED INC DATE OF NAME CHANGE: 20000128 8-K/A 1 ef20047907_8ka.htm 8-K/A false 0001104506 0001104506 2025-04-24 2025-04-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2025 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 000-30739 54-1972729 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 700 US Highway 202/206 Bridgewater , New Jersey   08807 (Zip Code) (Address of principal executive offices)     Registrant’s telephone number, including area code: ( 908 ) 977-9900 Not Applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share INSM Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ EXPLANATORY NOTE Insmed Incorporated (the “Company”) is filing an amendment to its Current Report on Form 8-K filed with the Securities and Exchange Commission on April 24, 2025 (the “Original Form 8-K”) for the purpose of amending the Original Form 8-K solely to correct the disclosure in Exhibit 99.1 to the Original Form 8-K to reflect the increased conversion rate pursuant to the “make-whole” provisions of the Indenture, dated as of January 26, 2018, as supplemented by the Second Supplemental Indenture, dated as of May 13, 2021,   between the Company and Computershare Trust Company, N.A., as successor trustee to Wells Fargo Bank, National Association (collectively, the “Indenture”), governing the Company’s 0.75% Convertible Senior Notes due 2028 (the “Notes”), due to the Company’s delivery of a not